調查批次:CHT2017-02 | 檢體寄出日期:2017-04-10 | 報告回收截止日期:2017-04-17 | 回收份數:22 |
T3 檢驗院際品管調查結果: | ||
2.歷次品管檢體 T3 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
213 |
-2 |
-0.9 |
-0.1 |
0.9 |
-4 |
97 |
3 |
3.2 |
0.4 |
1.2 |
13 |
RH07b | RH07 | 4 |
2 |
3 |
175 |
-40 |
-18.6 |
-2.3 |
-0.9 |
-78 |
84 |
-10 |
-10.6 |
-1.3 |
-0.1 |
-44 |
RH14 | RH14 | 3 |
2 |
3 |
178 |
-37 |
-17.2 |
-2.2 |
-0.7 |
-72 |
79 |
-15 |
-16.0 |
-2.0 |
-0.6 |
-66 |
RH15 | RH15 | 7 |
2 |
5 |
209 |
-6 |
-2.8 |
-0.3 |
0.7 |
-12 |
93 |
-1 |
-1.1 |
-0.1 |
0.8 |
-4 |
CL009 | CL009 | 4 |
2 |
5 |
210 |
-5 |
-2.3 |
-0.3 |
0.7 |
-10 |
86 |
-8 |
-8.5 |
-1.1 |
0.1 |
-35 |
CL010 | CL010 | 3 |
2 |
5 |
210 |
-5 |
-2.3 |
-0.3 |
0.7 |
-10 |
92 |
-2 |
-2.1 |
-0.3 |
0.7 |
-9 |
CL012 | CL012 | 7 |
2 |
3 |
147 |
-68 |
-31.6 |
-4.0 |
-2.1 |
-132 |
64 |
-30 |
-31.9 |
-4.0 |
-2.1 |
-133 |
CL014a | CL014 | 7 |
2 |
3 |
183 |
-32 |
-14.9 |
-1.9 |
-0.5 |
-62 |
76 |
-18 |
-19.1 |
-2.4 |
-0.9 |
-80 |
CL015 | CL015 | 4 |
2 |
5 |
205 |
-10 |
-4.7 |
-0.6 |
0.5 |
-19 |
91 |
-3 |
-3.2 |
-0.4 |
0.6 |
-13 |
Median of RIA Group |
205 |
86 |
||||||||||||||
Range of RIA Group |
147 - 213 |
64 - 97 |
||||||||||||||
Robust mean of RIA Group |
194 ( n = 9 ) |
85 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
22.3 |
10.0 |
||||||||||||||
CV of RIA Group |
11.5% |
11.8% |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 2 |
4 |
9 |
175 |
-40 |
-18.6 |
-2.3 |
-1.4 |
-78 |
71 |
-23 |
-24.5 |
-3.1 |
-1.4 |
-102 |
RH02c | RH02 | 3 |
4 |
1 |
240 |
25 |
11.6 |
1.5 |
0.9 |
48 |
103 |
9 |
9.6 |
1.2 |
0.6 |
40 |
RH06 | RH06 | 7 |
4 |
9 |
202 |
-13 |
-6.0 |
-0.8 |
-0.4 |
-25 |
79 |
-15 |
-16.0 |
-2.0 |
-0.9 |
-66 |
RH07a | RH07 | 2 |
4 |
2 |
194 |
-21 |
-9.8 |
-1.2 |
-0.7 |
-41 |
90 |
-4 |
-4.3 |
-0.5 |
-0.2 |
-18 |
RH12 | RH12 | 7 |
4 |
2 |
196 |
-19 |
-8.8 |
-1.1 |
-0.6 |
-37 |
85 |
-9 |
-9.6 |
-1.2 |
-0.5 |
-40 |
RH15b | RH15b | 4 |
4 |
13 |
253 |
38 |
17.7 |
2.2 |
1.4 |
74 |
113 |
19 |
20.2 |
2.5 |
1.3 |
84 |
RH19 | RH19 | 2 |
4 |
2 |
203 |
-12 |
-5.6 |
-0.7 |
-0.4 |
-23 |
101 |
7 |
7.4 |
0.9 |
0.5 |
31 |
RH20 | RH20 | 4 |
4 |
7 |
244 |
29 |
13.5 |
1.7 |
1.0 |
56 |
109 |
15 |
16.0 |
2.0 |
1.0 |
66 |
CL005 | CL005 | 4 |
4 |
9 |
198 |
-17 |
-7.9 |
-1.0 |
-0.6 |
-33 |
77 |
-17 |
-18.1 |
-2.3 |
-1.0 |
-75 |
CL006a | CL006 | 2 |
4 |
1 |
235 |
20 |
9.3 |
1.2 |
0.7 |
39 |
94 |
0 |
0.0 |
0.0 |
0.1 |
0 |
CL008 | CL008 | 7 |
4 |
2 |
207 |
-8 |
-3.7 |
-0.5 |
-0.2 |
-16 |
95 |
1 |
1.1 |
0.1 |
0.1 |
4 |
CL011 | CL011 | 1 |
4 |
13 |
243 |
28 |
13.0 |
1.6 |
1.0 |
54 |
108 |
14 |
14.9 |
1.9 |
1.0 |
62 |
CL013b | CL013b | 7 |
4 |
1 |
193 |
-22 |
-10.2 |
-1.3 |
-0.7 |
-43 |
80 |
-14 |
-14.9 |
-1.9 |
-0.8 |
-62 |
Median of CLIA Group |
203 |
94 |
||||||||||||||
Range of CLIA Group |
175 - 253 |
71 - 113 |
||||||||||||||
Robust mean of CLIA Group |
214 ( n = 13 ) |
93 ( n = 13 ) |
||||||||||||||
Robust SD of CLIA Group |
28.6 |
15.4 |
||||||||||||||
CV of CLIA Group |
13.4% |
16.6% |
||||||||||||||
Median of All Labs |
204 |
91 |
||||||||||||||
Range of All Labs |
147 - 253 |
64 - 113 |
||||||||||||||
Robust mean of All Labs |
206 ( n = 22 ) |
90 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
27.0 |
13.7 |
||||||||||||||
CV of All Labs |
13.1% |
15.2%
|
||||||||||||||
Certified assigned value ( Xa )( ng/dL ) |
215 |
94 |
||||||||||||||
Expanded uncertainty ( Ua ) |
2.28 |
0.91 |
||||||||||||||
Relative expanded uncertainty |
1.0% |
1.0% |
||||||||||||||
Coverage factor k |
2.6 |
2.6 |
||||||||||||||
Effective degrees of freedom veff |
5 |
5 |
||||||||||||||
SD for proficiency assessment ( σp ) |
17.20 |
7.52 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL006a, CL013b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL014a, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL015, |
Siemens ADVIA Centaur |
7 |
RH20, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-04-18